SENATE DOCKET, NO. 396 FILED ON: 1/19/2011
SENATE . . . . . . . . . . . . . . No. 992
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Steven A. Tolman
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to eliminate the abuse of controlled-release hydromorphone..
_______________
PETITION OF:
Name: | District/Address: |
Steven A. Tolman |
|
SENATE DOCKET, NO. 396 FILED ON: 1/19/2011
SENATE . . . . . . . . . . . . . . No. 992
By Mr. Tolman, petition (accompanied by bill, Senate, No. 992) of Tolman for legislation to eliminate the abuse of controlled-relase hydromorphone [Joint Committee on Mental Health and Substance Abuse]. |
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 756 OF 2009-2010.]
The Commonwealth of Massachusetts
_______________
In the Year Two Thousand Eleven
_______________
An Act to eliminate the abuse of controlled-release hydromorphone..
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Chapter 94C of the General Laws, as appearing in the 2002 Official Edition, is hereby amended by inserting after section 3 the following section:-
Section 3A. Notwithstanding sections 2 and 3, any preparation which contains hydromorphone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as delay absorption into the blood system, unless the preparation contains 1 or more active nonnarcotic ingredients in recognized therapeutic amounts, shall be in schedule I.
SECTION 2. Section 31 of said chapter 94C of the General Laws, as so appearing, is hereby amended by inserting after line 85, the following paragraph:-
Any preparation, which contains hydromorphone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as delay absorption into the blood system, unless the preparation contains 1 or more active nonnarcotic ingredients in recognized therapeutic amounts.